HP
VTRS icon

HealthInvest Partners’s Viatris VTRS Stock Holding History

HealthInvest Partners’s Portfolio VTRS Stock Details VTRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$5.29M Sell
475,000
-5,000
-1% -$52.3K 10.21% 4
2022
Q3 		$4.09M Buy
480,000
+170,000
+55% +$1.67M 8.64% 8
2022
Q2 		$3.25M Buy
+310,000
New +$3.4M 7.48% 9
2021
Q1 		– Sell
-525,000
Closed -$9.84M – 19
2020
Q4 		$9.84M Buy
+525,000
New +$8.56M 6.52% 3

Other funds holding VTRS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

HealthInvest Partners's VTRS Position: Q4 2022 in Review

HealthInvest Partners reduced its Viatris (VTRS) stake by 1% in Q4 2022, selling an estimated $52.3K and leaving 475,000 shares worth $5.29M. The position accounts for 10.21% of the portfolio, ranked #4.

HealthInvest Partners first reported a position in VTRS in Q4 2020 and has held it in 4 quarters since. The position peaked at $9.84M in Q4 2020. 1,016 funds tracked by Wall St. Rank hold VTRS as of Q4 2022.

  • HealthInvest Partners held 475,000 shares of Viatris worth $5.29M as of Q4 2022.
  • HealthInvest Partners sold 5,000 Viatris shares in Q4 2022, an estimated $52.3K.
  • Viatris made up 10.21% of HealthInvest Partners's portfolio in Q4 2022, its #4 holding.
  • HealthInvest Partners first reported a position in Viatris in Q4 2020 and has held it in 4 quarters since.
  • HealthInvest Partners's Viatris position peaked at $9.84M in Q4 2020.
  • 1,016 funds tracked by Wall St. Rank held Viatris as of Q4 2022.

Based on HealthInvest Partners's 13F filing for Q4 2022, filed 14 Feb 2023.